Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dihong Yang"'
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjectives This study investigated the impact of early cyclosporin A (CsA) initiation (day −5) on the risk of acute graft versus host disease (aGvHD) after allogeneic haematopoietic cell transplantation (allo-HSCT).Methods Sixty-seven leuka
Externí odkaz:
https://doaj.org/article/9ff2e1c3a2cf4f27820af5c1b509b9cf
Publikováno v:
Journal of Theoretical and Applied Electronic Commerce Research, Vol 18, Iss 1, Pp 394-415 (2023)
Accounts receivable financing is one of the most prominent financing approaches in supply chain finance; nevertheless, in the actual financing process, financial institutions and SMEs have credit risk and information asymmetry risk, which leads to fr
Externí odkaz:
https://doaj.org/article/dd207b67cd474497a937f157e1344d68
Publikováno v:
PeerJ, Vol 11, p e16207 (2023)
Background Lapatinib is an oral small-molecule tyrosine kinase inhibitor indicated for advanced or metastatic HER2-positive breast cancer. In order to reduce the treatment cost, a high-fat enteral nutrition emulsion TPF-T was selected as a dose-spari
Externí odkaz:
https://doaj.org/article/ddcbe3f2f0214e7eaaae185475342839
Autor:
Gaoqi Xu, Dihong Yang, Qi Shu, Junfeng Zhu, Haiying Ding, Wenxiu Xin, Like Zhong, Liqin Zhu, Luo Fang
Publikováno v:
The Journal of Clinical Pharmacology.
Autor:
Gaoqi Xu, Dihong Yang, Qi Shu, Junfeng Zhu, Haiying Ding, Wenxiu Xin, Like Zhong, Liqin Zhu, Fang Luo
Purpose The objective of this study was to develop a population pharmacokinetic (popPK) model of anlotinib and to investigate the impact of various covariates in patients with malignant tumors. Methods A total of 407 anlotinib plasma concentrations f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e716123771a281c172f6a3361d39cbb5
https://doi.org/10.21203/rs.3.rs-2375943/v1
https://doi.org/10.21203/rs.3.rs-2375943/v1
Autor:
Yinghui Tong, Dihong Yang, Xiufang Mi, Yu Song, Wenxiu Xin, Like Zhong, Zheng Shi, Gaoqi Xu, Haiying Ding, Luo Fang
Publikováno v:
Ann Transl Med
BACKGROUND: Despite the vital role of blood perfusion in tumor progression, the prognostic value of typical blood perfusion markers, such as microvessel density (MVD) or microvessel area (MVA), in patients with non-small cell lung cancer (NSCLC) is s